Ultragenyx Pharmaceutical, Inc. (RARE)
14.30
-0.10
(-0.69%)
USD |
NASDAQ |
Sep 11, 16:00
14.30
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Debt to Equity Ratio : -4.131 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.131 |
| March 31, 2026 | -5.085 |
| December 31, 2025 | -15.65 |
| September 30, 2025 | 94.24 |
| June 30, 2025 | 5.836 |
| March 31, 2025 | 6.168 |
| December 31, 2024 | 3.564 |
| September 30, 2024 | 2.631 |
| June 30, 2024 | 2.143 |
| March 31, 2024 | 6.646 |
| December 31, 2023 | 3.394 |
| September 30, 2023 | 30.04 |
| June 30, 2023 | 7.211 |
| March 31, 2023 | 4.166 |
| December 31, 2022 | 2.573 |
| September 30, 2022 | 1.913 |
| June 30, 2022 | 0.5847 |
| March 31, 2022 | 0.496 |
| December 31, 2021 | 0.4268 |
| September 30, 2021 | 0.42 |
| June 30, 2021 | 0.4014 |
| March 31, 2021 | 0.3663 |
| December 31, 2020 | 0.3326 |
| September 30, 2020 | 0.5636 |
| June 30, 2020 | 0.531 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.5964 |
| December 31, 2019 | 0.539 |
| September 30, 2019 | 0.0529 |
| June 30, 2019 | 0.0488 |
| March 31, 2019 | 0.0319 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AbbVie, Inc. | -11.93 |
| Biogen, Inc. | 0.4433 |
| BioMarin Pharmaceutical, Inc. | 0.6672 |
| Ionis Pharmaceuticals, Inc. | 4.978 |
| Regeneron Pharmaceuticals, Inc. | 0.0854 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.264B |
| Total Liabilities (Quarterly) | 1.548B |
| Shareholders Equity (Quarterly) | -291.00M |
| Current Ratio | 1.726 |
| Net Debt Paydown Yield | -1.90% |